During the past decade, Klinikum Lüdenscheid conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Lüdenscheid" #1 sponsor was "University of Ulm" with 5 trials, followed by "Abbott Medical Devices" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Lüdenscheid" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Central European Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Lüdenscheid" are "Heart Failure" (9 trials), "Acute Myeloid Leukemia" (6 trials), "Atrial Fibrillation" (6 trials), "Acute Myeloid Leukemia (AML)" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Klinikum Lüdenscheid" in a lesser frequency.

Most popular intervention types in "Klinikum Lüdenscheid" are "Drug" (23 trials), "Device" (11 trials), "Other" (6 trials), "Biological" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cytarabine" (3 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Lüdenscheid" are 43 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Lüdenscheid". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Klinikum Lüdenscheid, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Lüdenscheid, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".